Brind.

Cognition Therapeutics received grant support from the NIH segment on July 12, 2025, for a clinical study.

3 reports, 2 independent Updated Nov 2
Gone quiet
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Cognition Therapeutics received grant support from the NIH segment on July 12, 2025, for a clinical study.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • manilatimes.net
  • Insider MonkeyCognition Therapeutics, Inc. (CGTX) Retains Buy Rating on START Study Progress Cognition Therapeutics, Inc. (NASDAQ:CGTX) is among the fundamentally strong penny stocks to invest in. H.C. Wainwright
  • Unknown outlet